Sacha , T. (2013). Early molecular response as a criterion of optimal response to chronic myeloid leukemia treatment with tyrosine kinase inhibitors. OncoReview, 3(2(10), 80-84. Retrieved from https://journalsmededu.pl/index.php/OncoReview/article/view/333